Incident Use of Testosterone Products Among All Members and Members with Pre-Existing Testosterone Use

    Basic Details
    Date Posted
    Friday, June 3, 2016
    Status
    Complete
    Medical Product
    Androgel
    Axiron
    Fortesta
    intramuscular testosterone
    methyltestosterone
    Striant
    Testim
    testosterone
    testosterone cypionate
    testosterone enanthate
    testosterone pellet
    testosterone propionate
    testosterone suspension
    transdermal testosterone
    Description

    Modular program-based one-time assessment of the incident use of testosterone products among members with pre-existing testosterone use and members with no pre-existing inclusions or exclusions. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2007 to May 31, 2013. Modular programs are adaptable standardized programs. Results were generated using Modular Program 3, version 1.0; click here for more information.  Queries were distributed in March 2014. This report includes data from 18 Data Partners.
     
    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by sending an email requesting assistance to info@sentinelsystem.org.
     
    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2007 - May 31, 2013
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All individuals with pre-existing testosterone use
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)